Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-12 of 12 for your search:
Drug:
EF5
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Pilot Study of Etanidazole Derivative EF5 for the Measurement of Tumor Hypoxia in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
Phase:
Phase II
Type:
Diagnostic
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DUMC-0041-M1RB00622
, NCI-2310, NCT00041028, 2310
2.
Phase II Pilot Diagnostic Study of EF5 Uptake and Concentration of Oxygen-Related Metabolites in Patients With Head and Neck Cancer
Phase:
Phase II
Type:
Diagnostic
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DUMC-3512-02-3
, NCI-5929, NCT00049140, 5929
3.
Phase II Randomized Study of Hyperbaric Oxygen Treatments in Previously Treated Patients With Laryngeal or Adjacent Pharyngeal Malignancies Undergoing Laryngectomy
Phase:
Phase II
Type:
Supportive care, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCCAM, NCI
Protocol IDs:
UPCC-17300
, NCI-5909, UPCC-IRB-702641, 5909, NCT00026975
4.
Phase II Pilot Study of EF5 Binding for the Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
Phase:
Phase II
Type:
Diagnostic, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-03804
, 7034, NCI-7034, NCT00107445
5.
Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Solid Tumors
Phase:
Phase I
Type:
Diagnostic, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-7597
, NCI-T97-0045, NCT00003282, T97-0045, UPCC-1663-0
6.
Phase I Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia in Patients With Breast, Head and Neck, Prostate, or Cervical Carcinoma or High Grade Soft Tissue Sarcomas (Summary Last Modified 06/2002)
Phase:
Phase I
Type:
Diagnostic
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CAN-OCI-T98-0048
, NCI-T98-0048, NCT00004261, T98-0048
7.
Phase I Study of Positron Emission Tomography Using Fluorine F 18 EF5 for the Detection of Tumor Hypoxia in Patients With Newly Diagnosed Brain Tumors Undergoing Surgery or Biopsy
Phase:
Phase I
Type:
Diagnostic, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-01304
, NCI-5999, 5999, NCT00110032
8.
Study of Etanidazole Derivative EF5 for Detection of Tumor Hypoxia in Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Gliomas
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-1301
, UPCC-IRB-702859, NCI-4950, 4950, NCT00430079
9.
Study of the Etanidazole Derivative EF5 for the Detection of Hypoxia and Vascularity in Patients With Intraperitoneal or Pleural Malignancies Treated With Photodynamic Therapy
Phase:
No phase specified
Type:
Diagnostic
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-05901
, NCI-4110, 4110, UPCC-IRB-702341, NCT00028782
10.
Study of EF5 for the Detection of Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma of the Trunk or Extremity or Squamous Cell Carcinoma of the Oral Cavity
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-3300
, UPCC-IRB-701019, NCI-3950, 3950
11.
Diagnostic Study of EF5 Binding for the Detection of Tumor Hypoxia in Patients With Stage IIB, IIIB, or IVA Cervical Cancer
Phase:
No phase specified
Type:
Diagnostic
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
GOG-8002
, NCT00049231
12.
Diagnostic Study of the Distribution of EF5 for the Detection of Tumor Hypoxia and Motexafin Lutetium in Patients With Intra-Abdominal Malignancies or Non-Small Cell Lung Cancer
Phase:
No phase specified
Type:
Diagnostic
Status:
Completed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-04204
, NCI-6508, 6508, NCT00087191
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute